Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe Pain
Clinical trial NCT06379165 · COMPLETED
Trial details
- NCT number
- NCT06379165
- Sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-17
- Primary completion
- 2023-07-11
- Enrollment
- 192
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.